Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES

Watchlist Manager
Advanced Enzyme Technologies Ltd Logo
Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES
Watchlist
Price: 356.65 INR -1.26% Market Closed
Market Cap: 39.9B INR
Have any thoughts about
Advanced Enzyme Technologies Ltd?
Write Note

Net Margin
Advanced Enzyme Technologies Ltd

22.1%
Current
21%
Average
4.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
22.1%
=
Net Income
1.4B
/
Revenue
6.2B

Net Margin Across Competitors

Country IN
Market Cap 39.9B INR
Net Margin
22%
Country US
Market Cap 86.3B USD
Net Margin
11%
Country US
Market Cap 67.4B USD
Net Margin
13%
Country JP
Market Cap 10.1T JPY
Net Margin
21%
Country CH
Market Cap 36.5B CHF
Net Margin
15%
Country US
Market Cap 32B USD
Net Margin
7%
Country CN
Market Cap 232.7B CNY
Net Margin
8%
Country US
Market Cap 27.8B USD
Net Margin
8%
Country CH
Market Cap 26.1B EUR
Net Margin
20%
Country IN
Market Cap 2.2T INR
Net Margin
13%
Country DK
Market Cap 165.6B DKK
Net Margin
17%
No Stocks Found

Advanced Enzyme Technologies Ltd
Glance View

Market Cap
39.9B INR
Industry
Chemicals

Advanced Enzyme Technologies Ltd. engages in the research, development, manufacture, and sale of enzyme products. The company is headquartered in Thane, Maharashtra and currently employs 322 full-time employees. The company went IPO on 2016-08-01. The firm is focused on the research and development, manufacturing and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. The company provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit and vegetable processing, brewing and malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others. The company offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather and bio-fuels. Its oils and fats processing include oil extraction, oil refining fish oil processing, biodiesel and oleochemicals.

ADVENZYMES Intrinsic Value
270 INR
Overvaluation 24%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
22.1%
=
Net Income
1.4B
/
Revenue
6.2B
What is the Net Margin of Advanced Enzyme Technologies Ltd?

Based on Advanced Enzyme Technologies Ltd's most recent financial statements, the company has Net Margin of 22.1%.